Oculus Innovative Sciences Announces Preliminary Results From 40-Patient Feasibility Study For Treatment Of Acne With The Microcyn(R) Technology
Oculus Innovative Sciences, Inc. (Nasdaq OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, announced that preliminary results from its U.S. 40patient feasibility study, in which an enhanced formulation of the companys Microcyn Technologybased hydrogel was used in the treatment of acne, are highly encouraging [...]